Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
59 participants
INTERVENTIONAL
2016-01-01
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Diurnal Rhythm in Natriuretic Peptide Levels
NCT03834168
Mechanisms of Refractory Hypertension (High and Low Salt Diet)
NCT02357017
Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans
NCT04021355
Effect of Dietary Sodium Intake on Blood Pressure in Hypertensive Patients in Primary Care
NCT01334138
Nocturnal Blood Pressure and Hypertension - Central and Peripheral 24-h Blood Pressure.
NCT02078765
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High sodium diet
High sodium diet is 6 g sodium per day for 10 days
Dietary sodium
High (6 g) versus low (1.5 g) sodium diet
Low sodium diet
Low sodium diet is 1.5 g sodium per day for 10 days
Dietary sodium
High (6 g) versus low (1.5 g) sodium diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary sodium
High (6 g) versus low (1.5 g) sodium diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of congestive heart failure
* Chronic kidney disease,
* Diabetes with insulin use
* History of a cardiovascular event
* Pregnant or nursing
* Current use of continuous positive airway pressure
* Shift work
* A known circadian rhythm disorder
48 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Heart Association
OTHER
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Calhoun
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Calhoun, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
David A. Calhoun, MD
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F150508004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.